https://peptide.global/2026-10-27 https://peptide.global/archive2026-10-27 https://peptide.global/atlas2026-10-27 https://peptide.global/bay/plants2026-10-24 https://peptide.global/bay/process2026-10-26 https://peptide.global/bay/trade2026-10-25 https://peptide.global/bay/deals2026-10-27 https://peptide.global/about2026-10-28 https://peptide.global/editorial-policy2026-10-28 https://peptide.global/contact2026-10-28 https://peptide.global/privacy-policy2026-10-28 https://peptide.global/terms2026-10-28 https://peptide.global/story/polypeptide-samsung-board-slate-approved2026-10-27https://peptide.global/images/gen/polypeptide-samsung-board-slate-approved.svg https://peptide.global/story/daewon-oral-semaglutide-dw5324-rybelsus2026-10-26https://peptide.global/images/gen/daewon-oral-semaglutide-tablet-dw5324-beats-rybelsus-exposure-in-two-small-studies.svg https://peptide.global/story/oral-peptide-softgels-lipid-fills2026-10-26https://peptide.global/images/gen/oral-peptide-softgels-use-lipid-fills-and-matched-shells-to-carry-fragile-drugs-through-th.svg https://peptide.global/story/torrent-semaglutide-brazil-launch2026-10-25https://peptide.global/images/gen/torrent-semaglutide-brazil-launch-targeted-within-nine-months-but-the-maker-behind-it-is-u.svg https://peptide.global/story/gilead-pepstar-oral-il-23r-peptide2026-10-25https://peptide.global/images/gen/gilead-pepstar-deal-buys-an-oral-il-23r-peptide-for-1-275-billion-with-no-plant-attached.svg https://peptide.global/story/semaglutide-patent-expiry-map2026-10-25https://peptide.global/images/gen/semaglutide-patent-expiry-map-shows-copies-in-india-canada-and-brazil-while-china-waits-un.svg https://peptide.global/story/outbound-investment-rule-chinese-biomanufacturing2026-10-25https://peptide.global/images/gen/outbound-investment-biotech-rule-puts-us-stakes-in-chinese-biomanufacturing-plants-under-t.svg https://peptide.global/story/dr-reddys-semaglutide-restart-validation-batches2026-10-25https://peptide.global/images/gen/dr-reddys-semaglutide-restart-hangs-on-three-validation-batches-after-a-scale-up-impurity.svg https://peptide.global/story/sanofi-frankfurt-insulin-plant-breaks-ground2026-10-24https://peptide.global/images/gen/sanofi-insulin-plant-in-frankfurt-breaks-ground-with-supply-duties-that-run-to-2042.svg https://peptide.global/story/sri-lanka-koggala-insulin-factory2026-10-24https://peptide.global/images/gen/sri-lanka-insulin-factory-in-koggala-is-built-and-targets-first-output-in-2027.svg https://peptide.global/story/ql-biopharm-wuxi-glp-1-e-coli2026-10-24https://peptide.global/images/gen/ql-biopharm-wuxi-base-will-make-its-glp-1-peptides-with-an-e-coli-process.svg https://peptide.global/story/hybio-peptide-api-profit-fivefold2026-10-24https://peptide.global/images/gen/hybio-peptide-api-sales-lift-profit-fivefold-as-its-expansion-placement-lapses.svg https://peptide.global/story/mhra-counterfeit-weight-loss-pens-birmingham2026-10-24https://peptide.global/images/gen/mhra-counterfeit-weight-loss-pens-haul-in-birmingham-shows-illicit-packing-at-scale.svg https://peptide.global/story/samsung-biologics-polypeptide-tender2026-10-23https://peptide.global/images/gen/samsung-biologics-polypeptide-tender-clears-its-bar-as-songdo-keeps-booking-biologics-work.svg https://peptide.global/story/dupont-amberchrom-sil-peptide-purification2026-10-23https://peptide.global/images/gen/dupont-amberchrom-sil-adds-reverse-phase-silica-to-peptide-purification-lines.svg https://peptide.global/story/fda-import-alert-chinese-glp-1-plants2026-10-23https://peptide.global/images/gen/fda-import-alert-shuts-out-two-chinese-glp-1-ingredient-plants.svg https://peptide.global/story/kilitch-ethiopia-sale-funds-pen-site2026-10-23https://peptide.global/images/gen/kilitch-drugs-ethiopia-sale-funds-a-new-pen-site-with-glp-1-on-the-plan.svg https://peptide.global/story/lilly-mubadala-glp-1-packaging-abu-dhabi2026-10-23https://peptide.global/images/gen/lilly-mubadala-bio-deal-adds-a-glp-1-packaging-stage-at-a-kezad-site-in-abu-dhabi.svg https://peptide.global/story/chinese-semaglutide-copies-patent-end2026-01-20https://peptide.global/images/photos/hangzhou.jpg https://peptide.global/story/biosecure-act-passes-chinese-biotech-suppliers2025-12-18https://peptide.global/images/photos/capitol.jpg https://peptide.global/story/us-100-percent-tariff-branded-drugs2025-09-26https://peptide.global/images/photos/port-cranes.jpg https://peptide.global/story/lilly-houston-plant-glp-1-pill2025-09-23https://peptide.global/mol:zero:tirzepatide https://peptide.global/story/eu-us-15-percent-cap-medicines2025-08-21https://peptide.global/images/photos/berlaymont.jpg https://peptide.global/story/yeast-resin-glp-1-peptide-production2025-06-10https://peptide.global/mol:compare:semaglutide:tirzepatide https://peptide.global/story/bachem-bubendorf-peptide-building-starts2025-04-24https://peptide.global/images/photos/bubendorf.jpg https://peptide.global/story/peptide-drug-kilo-thousands-kilos-material2025-03-18https://peptide.global/images/photos/drums.jpg https://peptide.global/story/lilly-four-us-plants-27-billion2025-02-26https://peptide.global/images/photos/lilly-indianapolis.jpg https://peptide.global/story/catalent-deal-closes-novo-nordisk2024-12-18https://peptide.global/images/photos/catalent-swindon.jpg https://peptide.global/story/novo-nordisk-clayton-fill-finish-plant2024-06-24https://peptide.global/images/photos/ozempic-pen.jpg https://peptide.global/story/novo-nordisk-dkk-42-billion-kalundborg2024-06-12https://peptide.global/images/photos/kalundborg.jpg https://peptide.global/story/lilly-buys-pleasant-prairie-injectables-plant2024-06-04https://peptide.global/images/photos/cleanroom.jpg https://peptide.global/story/lilly-lebanon-indiana-9-billion-tirzepatide2024-05-14https://peptide.global/images/photos/mounjaro-pen.jpg https://peptide.global/story/cordenpharma-900-million-peptide-capacity2024-02-20https://peptide.global/images/photos/synthesizer.jpg https://peptide.global/story/lilly-alzey-germany-injectables-plant2023-11-17https://peptide.global/images/photos/alzey.jpg